Skip to content

A prospective clinical study on the observation of radiation-related side effects in thoracic malignancy with proton or carbon ion radiotherapy

A prospective clinical study on the observation of radiation-related side effects in thoracic malignancy with proton or carbon ion radiotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115018
Enrollment
Unknown
Registered
2025-12-21
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic malignancy

Interventions

Proton and carbon ion radiotherapy group:NA

Sponsors

Shanghai Proton and Heavy Ion Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Informed consent achieved. 2. 16 years old or more. 3. Received no chest radiotherapy before, and had no contraindications to radiotherapy. 4. Be able to comply with this protocol. 5. Adequate organ function.

Exclusion criteria

Exclusion criteria: 1. Received chest radiotherapy or radioactive seed implantation before; 2. Be unable to understand the purpose of treatment or unwilling/unable to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Radiation-induced toxicity;

Countries

China

Contacts

Public ContactWu Kailiang

Shanghai Proton and Heavy Ion Center

kailiang.wu@sphic.org.cn+86 21 3829 6666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026